AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 26879784
Drug: Quadruple regimen
RxNorm normalized name: Anacin Aspirin Regimen Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Quadruple regimen (rabeprazole + amoxicillin + clarithromycin + bismuth potassium citrate) for 10 days followed by bismuth-placebo for 21 days (Group A1)
Trial: 23542218
Drug: Constraint-Induced Movement
RxNorm normalized name: constant albicans extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Constraint-Induced Movement Therapy (CIMT-D) administered 15 to 21 months poststroke
Trial: 17181922
Drug: Sham HT
RxNorm normalized name: 5-HT
DrugBank: Serotonin (DB08839)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sham HT administered for 40 minutes daily for 5 days per week for two weeks
Trial: 18820977
Drug: Oral polyethylene
RxNorm normalized name: polyethylenes
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral polyethylene glycol (Group A)
Trial: 12131185
Drug: IL-2 plus
RxNorm normalized name: IL-2
DrugBank: Human interleukin-2 (DB14865)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: IL-2 plus HAART (9 megaunits daily for 5 days in 6-week intervals for a total of eight cycles)
Trial: 3964332
Drug: Preparation A
RxNorm normalized name: POVIDONE-IODINE 75 mg in 1 mL TOPICAL SOLUTION [Antiseptic Patient Preoperative Skin Preparation and Surgical Hand Scrub]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Preparation A (hard gelatine capsule with pellets)
Trial: 22652990
Drug: Caudal epidural
RxNorm normalized name: epidermal growth factor
DrugBank: Nepidermin (DB14145)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Caudal epidural injections of local anesthetic (lidocaine 0.5%)
Trial: 27729766
Drug: 600 mg
RxNorm normalized name: mesna 600 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 600 mg ALA
Trial: 7721409
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of enalapril and candoxatrilat
Trial: 1959863
Drug: 750 mg
RxNorm normalized name: bran 750 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 750 mg ursodeoxycholic acid alone (group A)
Trial: 1959863
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of 500 mg ursodeoxycholic acid and 500 mg chenodeoxycholic acid (group B)
Trial: 25928772
Drug: Daily cell
RxNorm normalized name: AVOBENZONE 30 mg in 1 g / HOMOSALATE 100 mg in 1 g / OCTISALATE 50 mg in 1 g / OCTOCRYLENE 10 mg in 1 g / OXYBENZONE 50 mg in 1 g TOPICAL CREAM [ReVive Sensitif Renewal Daily Cellular Protection Broad Spectrum SPF 30 Sunscreen]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Daily cell phone support intervention
Trial: 19996415
Drug: Intracoronary infusion
RxNorm normalized name: Duo Fusion
DrugBank: Magnesium hydroxide (DB09104)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intracoronary infusion of bone marrow-derived progenitor cells (BMC)
Trial: 22471392
Drug: Atenolol 75
RxNorm normalized name: Atenolol
DrugBank: Atenolol (DB00335)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Atenolol 75 mg for 4 weeks
Trial: 15681624
Drug: Testosterone gel
RxNorm normalized name: Androgel 1.62% Metered Dose Pump Testosterone Gel
DrugBank: (1,2,6,7-3H)Testosterone (DB14093)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Testosterone gel 1% (5 g applied once a day)
Trial: 17066085
Drug: Perindopril 4
RxNorm normalized name: perindopril 4 mg oral tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Perindopril 4 mg + Indapamide 1.25 mg
Trial: 2806927
Drug: levodopa administration
RxNorm normalized name: Levodopa
DrugBank: Levodopa (DB01235)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: levodopa administration
Trial: 15189916
Drug: Influenza vaccination
RxNorm normalized name: Haemophilus influenzae b (Ross strain) capsular polysaccharide meningococcal protein conjugate vaccine Injection [PedvaxHIB]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Influenza vaccination (purified, trivalent, split-virus vaccine)
Trial: 15704358
Drug: Penicillin V
RxNorm normalized name: Penicillin V
DrugBank: Phenoxymethylpenicillin (DB00417)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Penicillin V (50,000 IU/kg, divided in three doses for 10 days)
Trial: 27548030
Drug: Modular treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Modular treatment (MATCH)
Trial: 21178605
Drug: Preemptive thoracic
RxNorm normalized name: Thoracol
DrugBank: Menthol (DB14123)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Preemptive thoracic epidural analgesia without ketamine (0.12% levobupivacaine, 2 μg/mL of fentanyl, total volume of 500 mL)
Trial: 21178605
Drug: Preemptive low-dose
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Preemptive low-dose epidural ketamine
Trial: 24149855
Drug: Negative pressure
RxNorm normalized name: DRESSING,NEGATIVE PRESSURE WOUND
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Negative pressure wound therapy (NPWT) combined with dynamic fascial sutures (DFS)
Trial: 9226591
Drug: Rifampicin 1200
RxNorm normalized name: Rifampicine
DrugBank: Rifampin (DB01045)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rifampicin 1200 mg
Trial: 11874927
Drug: Buffered Regular
RxNorm normalized name: INSULIN,REGULAR,HUMAN BUFFERED
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Buffered Regular Insulin (BR)
Trial: 7851193
Drug: Controlled-release mesalamine
RxNorm normalized name: mesalamine Delayed Release Oral Tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Controlled-release mesalamine at 4 g/day for 12 months
Trial: 9034984
Drug: Meloxicam 15
RxNorm normalized name: meloxicam 15 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Meloxicam 15 mg once daily
Trial: 3287907
Drug: Piroxicam 20
RxNorm normalized name: piroxicam 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Piroxicam 20 mg
Trial: 6437268
Drug: Intramuscular piritramide
RxNorm normalized name: piritramide
DrugBank: Piritramide (DB12492)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intramuscular piritramide
Trial: 21173411
Drug: Unblinded echinacea
RxNorm normalized name: Echinacea
DrugBank: Echinacea (DB14240)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Unblinded echinacea pills (10.2 g during the first 24 hours and 5.1 g during each of the next 4 days)
Trial: 9671427
Drug: Betaxolol hydrochloride
RxNorm normalized name: Betaxolol Hydrochloride
DrugBank: Betaxolol (DB00195)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Betaxolol hydrochloride 0.50% (Betoptic) administered to 15 POAG and 7 NTG eyes
Trial: 29107562
Drug: Delayed switch
RxNorm normalized name: Witch Hazel
DrugBank: Witch hazel (DB11111)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Delayed switch to Dolutegravir monotherapy
Trial: 3521859
Drug: Cimetropium bromide
RxNorm normalized name: cimetropium bromide
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cimetropium bromide (50 mg BID)
Trial: 22156542
Drug: Untreated control
RxNorm normalized name: benzoyl peroxide
DrugBank: Benzoyl peroxide (DB09096)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Untreated control (UC) group at 67 μg/kg/day
Trial: 17827633
Drug: Initial antithrombin
RxNorm normalized name: antithrombin III
DrugBank: Antithrombin III human (DB11598)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Initial antithrombin (AT) levels at 15 mg/dL
Trial: 22098676
Drug: Inactivated influenza
RxNorm normalized name: influenza, inactivated, whole virus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Inactivated influenza vaccine
Trial: 3137888
Drug: Tegafur 400
RxNorm normalized name: tegafur
DrugBank: Tegafur (DB09256)
FDA approved: no
EMA approved: yes
PMDA approved: no
Description: Tegafur 400 mg/m2 alone (Group A)
Trial: 11841196
Drug: Beclomethasone dipropionate
RxNorm normalized name: Beclomethasone Dipropionate
DrugBank: Beclomethasone dipropionate (DB00394)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Beclomethasone dipropionate (BDP) 5 mg/d
Trial: 7526028
Drug: Chemotherapy with
RxNorm normalized name: Primatene with ephedrine Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Chemotherapy with ifosfamide, cisplatin, and adriamycin
Trial: 30660609
Drug: Nivolumab plus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nivolumab plus ipilimumab (Nivolumab 3 mg/kg every 2 weeks + Ipilimumab 1 mg/kg every 6 weeks)
Trial: 21663652
Drug: CBPR walking
RxNorm normalized name: ethanol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: CBPR walking intervention with social support walking groups, pedometer diary self-monitoring, monthly diet and physical activity education sessions, and individualized motivational interviewing sessions.
Trial: 9915282
Drug: High dose
RxNorm normalized name: INFLUENZA VACCINE HIGH DOSE 0.5ML SYR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High dose of dialysis (target eKt/V 1.45)
Trial: 29590422
Drug: Access to
RxNorm normalized name: Wong To Yick
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Access to non-pharmacologic treatments
Trial: 3160356
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of atenolol and nitrendipine (100 mg and 20 mg respectively, once daily)
Trial: 10733492
Drug: Chemotherapy (CTx)
RxNorm normalized name: menthol
DrugBank: Menthol (DB14123)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Chemotherapy (CTx)
Trial: 20301996
Drug: Continuous infusion
RxNorm normalized name: insulin pump cartridge,continuous infusion,BT and controller SUBCUT EACH
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Continuous infusion of vancomycin (15 mg/kg loading dose for 1 h followed by 30 mg/kg continuous infusion over 24 h for 48 h)
Trial: 20301996
Drug: Intermittent infusion
RxNorm normalized name: Duo Fusion
DrugBank: Magnesium hydroxide (DB09104)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intermittent infusion of vancomycin (15 mg/kg for 1 h every 12 h for 48 h)
Trial: 19149880
Drug: Active Physical
RxNorm normalized name: Activated Charcoal
DrugBank: Activated charcoal (DB09278)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Active Physical Therapy (APT)
Trial: 25223731
Drug: 10 mg
RxNorm normalized name: biotin 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10 mg selisistat
Trial: 12589529
Drug: Bovine surfactant
RxNorm normalized name: Pegademase Bovine
DrugBank: Pegademase (DB00061)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Bovine surfactant (100 mg/kg intratracheally under continuous ventilation and PEEP)
Trial: 10625850
Drug: Benzydamine hydrochloride
RxNorm normalized name: benzydamine hydrochloride
DrugBank: Benzydamine (DB09084)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Benzydamine hydrochloride 0.15% oral mouthwash 3 times a day for 4 weeks
Trial: 1942288
Drug: Pinacidil 25
RxNorm normalized name: pinacidil 25 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pinacidil 25 mg per day
Trial: 7863474
Drug: Olive oil
RxNorm normalized name: Olive Oil
DrugBank: Olive oil (DB09567)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Olive oil (4 x 1 g capsules, placebo)
Trial: 16173137
Drug: PYY infusion
RxNorm normalized name: Duo Fusion
DrugBank: Magnesium hydroxide (DB09104)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: PYY infusion
Trial: 10823256
Drug: Fixed dose
RxNorm normalized name: Humalog Mix
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fixed dose subcutaneous LMWH Certoparin (8,000 anti-factor Xa U b.i.d.)
Trial: 11408793
Drug: DA agonist
RxNorm normalized name: DAS-181
DrugBank: DAS-181 (DB15313)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: DA agonist (lisuride 0.2 mg)
Trial: 27373088
Drug: Budesonide treatment
RxNorm normalized name: Budesonide
DrugBank: Budesonide (DB01222)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Budesonide treatment
Trial: 23985625
Drug: Peramivir 300
RxNorm normalized name: Peramivir
DrugBank: Peramivir (DB06614)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Peramivir 300 mg twice daily
Trial: 8291866
Drug: Intravesical chemotherapy
RxNorm normalized name: Valrubicin Intravesical Solution
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravesical chemotherapy with doxorubicin (ADM)
Trial: 8291866
Drug: Intravesical chemotherapy
RxNorm normalized name: Valrubicin Intravesical Solution
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravesical chemotherapy with mitomycin C (MMC)
Trial: 8291866
Drug: Intravesical immunotherapy
RxNorm normalized name: Adoptive immunotherapy agent CTL019
DrugBank: Tisagenlecleucel (DB13881)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravesical immunotherapy with bacillus Calmette-Guérin (BCG)
Trial: 9181646
Drug: Alternating treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Alternating treatment with zidovudine 600 mg/day and didanosine 400 mg/day
Trial: 6396120
Drug: Clotrimazole applied
RxNorm normalized name: Clotrimazole
DrugBank: Clotrimazole (DB00257)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Clotrimazole applied twice daily
Trial: 30632413
Drug: Whey protein
RxNorm normalized name: Whey protein
DrugBank: Whey (DB18685)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Whey protein isolate (0.5 g·kg‐1·day‐1)
Trial: 30632413
Drug: Carbohydrate beverage
RxNorm normalized name: pyrrolidone carboxylate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Carbohydrate beverage (0.5 g·kg‐1·day‐1)
Trial: 26391570
Drug: Aspirin alone
RxNorm normalized name: Aspirin
DrugBank: Acetylsalicylic acid (DB00945)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Aspirin alone treatment (75 mg per day for 90 days)
Trial: 11157586
Drug: Long-term exercise
RxNorm normalized name: benzethonium
DrugBank: Benzethonium (DB11125)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Long-term exercise therapy (18 months)
Trial: 27315831
Drug: Basic SMS
RxNorm normalized name: Basic Fuchsin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Basic SMS reminder repeating the RDT result and appropriate treatment actions
Trial: 3903788
Drug: 40 mg
RxNorm normalized name: rutin 40 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 40 mg penbutolol alone
Trial: 3142454
Drug: Experimental group
RxNorm normalized name: Streptococcus viridans group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Experimental group (12 young men) using a device supplying 12.8% O2 for 7.5-8 hours daily for 10 days.
Trial: 30223315
Drug: Intravenous dexamethasone
RxNorm normalized name: Dexamethasone
DrugBank: Dexamethasone acetate (DB14649)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Intravenous dexamethasone 8 mg (IV)
Trial: 29872148
Drug: TEFOX regimen
RxNorm normalized name: Anacin Aspirin Regimen Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: TEFOX regimen (docetaxel 50 mg/m2, oxaliplatin 85 mg/m2, 5FU 2400 mg/m2) administered every 14 days
Trial: 23293111
Drug: Sequential docetaxel
RxNorm normalized name: Docetaxel
DrugBank: Docetaxel (DB01248)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Sequential docetaxel (A (75 mg/m(2)) × 3 → docetaxel (T (100 mg/m(2)) × 3 → CMF)
Trial: 16542199
Drug: Topical ibuprofen
RxNorm normalized name: ibuprofen Topical Cream
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical ibuprofen
Trial: 16601430
Drug: 100 mg
RxNorm normalized name: urea 100 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 100 mg PPS 3 times per day (300 mg/day)
Trial: 28283732
Drug: half-dose photodynamic
RxNorm normalized name: propranolol hydrochloride Extended Release Oral Capsule [Half-Betadur CR]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: half-dose photodynamic therapy (hd-PDT)
Trial: 3287813
Drug: Intravenous administration
RxNorm normalized name: intravenous administration set
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous administration of 50 mg indomethacin
Trial: 3287813
Drug: Rectal administration
RxNorm normalized name: polidocanol
DrugBank: Polidocanol (DB06811)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Rectal administration of 100 mg indomethacin
Trial: 379049
Drug: Hydrogen peroxide
RxNorm normalized name: Hydrogen Peroxide
DrugBank: Hydrogen peroxide (DB11091)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Hydrogen peroxide mouthwash (Amosan), 1.7 g powder dissolved in 30 ml hot tap water, rinsed after meals for 2 weeks
Trial: 17997772
Drug: Hot compresses
RxNorm normalized name: Red Hot
DrugBank: Capsaicin (DB06774)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Hot compresses (conservative treatment)
Trial: 16329018
Drug: Physostigmine 10
RxNorm normalized name: PHYSOSTIGMINE
DrugBank: Physostigmine (DB00981)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Physostigmine 10 micrograms/kg intravenously followed by meperidine 0.5 mg/kg intravenously (group 2)
Trial: 10436259
Drug: Insulin +
RxNorm normalized name: INSULIN
DrugBank: Insulin beef (DB09456)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Insulin + Gliclazide
Trial: 8828533
Drug: Oral budesonide
RxNorm normalized name: Budesonide
DrugBank: Budesonide (DB01222)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Oral budesonide
Trial: 31187264
Drug: High flow
RxNorm normalized name: Blood Set High Flow
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High flow nasal cannula at 4 L/min
Trial: 31187264
Drug: High flow
RxNorm normalized name: Blood Set High Flow
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High flow nasal cannula at 6 L/min
Trial: 30639763
Drug: Tablet-based screening
RxNorm normalized name: SUN PROTECTANTS/SCREENS,TOPICAL
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tablet-based screening
Trial: 12877822
Drug: Zafirlukast 40
RxNorm normalized name: Zafirlukast
DrugBank: Zafirlukast (DB00549)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Zafirlukast 40 mg
Trial: 2270301
Drug: Heparin lock
RxNorm normalized name: Heparin Lock Flush
DrugBank: Heparin (DB01109)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Heparin lock changed every 72 hours (Group A)
Trial: 2270301
Drug: Heparin lock
RxNorm normalized name: Heparin Lock Flush
DrugBank: Heparin (DB01109)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Heparin lock left in place up to 168 hours (Group B)
Trial: 8201130
Drug: 15-min exposure
RxNorm normalized name: Bacillus anthracis strain V770-NP1-R antigens
DrugBank: Anthrax vaccine (DB11003)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 15-min exposure to light daily
Trial: 30027479
Drug: New mint-flavored
RxNorm normalized name: nicotine
DrugBank: Nicotine (DB00184)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: New mint-flavored nicotine gum (2 mg)
Trial: 28002167
Drug: Ondansetron 4
RxNorm normalized name: ondansetron 4 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ondansetron 4 mg intravenously
Trial: 16439495
Drug: Daily activity
RxNorm normalized name: Activated Charcoal
DrugBank: Activated charcoal (DB09278)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Daily activity recording for 6 weeks
Trial: 6175136
Drug: Halcinonide cream
RxNorm normalized name: Halcinonide Cream
DrugBank: Halcinonide (DB06786)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Halcinonide cream (Halog) 0.1% (50 micrograms)
Trial: 3405343
Drug: Combined therapy
RxNorm normalized name: REGN10933+REGN10987 combination therapy
DrugBank: Anti-SARS-CoV-2 REGN-COV2 (DB15691)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combined therapy (adjuvant chemotherapy with cyclophosphane, methotrexate, 5‐fluorouracil)
Trial: 21607794
Drug: Mosapride 15
RxNorm normalized name: mosapride
DrugBank: Mosapride (DB11675)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Mosapride 15 mg by mouth three times a day starting on postoperative day 1
Trial: 10086255
Drug: Internal medicine
RxNorm normalized name: Medicaine Sting
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Internal medicine return visits
Trial: 11870439
Drug: Low-dose FDT
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low-dose FDT (S800, n=25)
Trial: 17006287
Drug: Hepatitis A
RxNorm normalized name: HEPATITIS A
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hepatitis A vaccine alone (dose 1)
Trial: 17006287
Drug: Hepatitis A
RxNorm normalized name: HEPATITIS A
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hepatitis A vaccine concomitantly with other vaccines
Trial: 20538418
Drug: Tramadol 50
RxNorm normalized name: traMADol 50 mg oral tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tramadol 50 mg, 4 times/day
Trial: 20538418
Drug: Morphine 15
RxNorm normalized name: morphine 15 MG/ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Morphine 15 mg, 4 times/day
Trial: 1773780
Drug: CBZ 600
RxNorm normalized name: CBZ
DrugBank: Carbamazepine (DB00564)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: CBZ 600 mg
Trial: 17138642
Drug: Ketoprofen patch
RxNorm normalized name: Ketoprofen
DrugBank: Ketoprofen (DB01009)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Ketoprofen patch 100 mg once daily
Trial: 18469247
Drug: Caffeinated coffee
RxNorm normalized name: Coffee bean
DrugBank: Coffee bean (DB10525)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Caffeinated coffee (5 mg/kg) with high glycemic index meal
Trial: 2567431
Drug: 10 mg
RxNorm normalized name: biotin 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10 mg of salbutamol in 2 ml (0.5 mg) of preservative‐free ipratropium bromide
Trial: 31559532
Drug: sc IFN
RxNorm normalized name: IFNγ
DrugBank: Interferon Gamma (DB15753)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: sc IFN β‐1a 44 µg tiw
Trial: 15310446
Drug: Lumbar epidural
RxNorm normalized name: epidermal growth factor
DrugBank: Nepidermin (DB14145)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lumbar epidural blockade with bupivacaine 0.25% (10 mg bolus and 5 mg/h continuous infusion)
Trial: 2530507
Drug: Hypertonic saline
RxNorm normalized name: ENTSOL Hypertonic Saline Nasal Gel
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hypertonic saline infusion (5%)
Trial: 9931893
Drug: Postoperative radiotherapy
RxNorm normalized name: sodium fluoride
DrugBank: Sodium fluoride (DB09325)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Postoperative radiotherapy (50.4 Gy) and 12 cycles of 5‐fluorouracil and medium‐dose folinic acid